Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: No discussion of the 890?..Opty...Questio...
1
Jun 07, 2008 06:10PM

Adding to my post:

Historically, there has been no reporting of dollar amounts accompanying the news releases of the new licensees with the exceptions of a few initial signings. The license amounts are held until Q reporting.

I'm certain there was discussion of this here at the time that TPL/PTSC adopted the 'policy' of not reporting the license amounts at the time of the news release but I can't remember the consensus shared among posters. Can it be said that new licensees are considered non-material events by SEC standards?

TIA,

Regards,
PxP

2
Jun 07, 2008 09:24PM
2
Jun 07, 2008 09:29PM
1
Jun 08, 2008 05:30AM
2
Jun 08, 2008 10:52AM
Share
New Message
Please login to post a reply